膿瘍(Abscess):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Abscess Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2692CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2015年5月27日
◆ページ数:149
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、世界における膿瘍(Abscess) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 膿瘍(Abscess)
  - 当レポートの概要
・膿瘍(Abscess):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Abscess Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Abscess Global Clinical Trials Review, H1, 2015″ provides an overview of Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Abscess 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Abscess to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Abscess to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Abscess 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Abscess Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
The Medicines Company 35
Clinical Trial Overview of The Medicines Company 35
Durata Therapeutics, Inc. 36
Clinical Trial Overview of Durata Therapeutics, Inc. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
C. H. Boehringer Sohn AG & Co. KG 38
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Anthem, Inc. 40
Clinical Trial Overview of Anthem, Inc. 40
Affinium Pharmaceuticals, Ltd. 41
Clinical Trial Overview of Affinium Pharmaceuticals, Ltd. 41
Actavis plc 42
Clinical Trial Overview of Actavis plc 42
Clinical Trial Overview of Top Institutes / Government 43
Washington University School of Medicine 43
Clinical Trial Overview of Washington University School of Medicine 43
Helsinki University Central Hospital 44
Clinical Trial Overview of Helsinki University Central Hospital 44
The Children’s Mercy Hospital 45
Clinical Trial Overview of The Children’s Mercy Hospital 45
Wilford Hall Medical Center 46
Clinical Trial Overview of Wilford Hall Medical Center 46
Aarhus University 47
Clinical Trial Overview of Aarhus University 47
Academic Medical Center 48
Clinical Trial Overview of Academic Medical Center 48
Ann & Robert H. Lurie Children’s Hospital of Chicago 49
Clinical Trial Overview of Ann & Robert H. Lurie Children’s Hospital of Chicago 49
Arak University of Medical Sciences 50
Clinical Trial Overview of Arak University of Medical Sciences 50
Baylor College of Medicine 51
Clinical Trial Overview of Baylor College of Medicine 51
Bayside Health 52
Clinical Trial Overview of Bayside Health 52
Five Key Clinical Profiles 53
Appendix 147
Abbreviations 147
Definitions 147
Research Methodology 148
Secondary Research 148
About GlobalData 149
Contact Us 149
Disclaimer 149
Source 149

List of Tables
Abscess Therapeutics, Global, Clinical Trials by Region, 2015* 7
Abscess Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Abscess Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Abscess Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Abscess Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Abscess Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Abscess Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Abscess Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Abscess to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Abscess Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Abscess Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Abscess to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Abscess Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Abscess Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Abscess Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Abscess Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Abscess Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Abscess Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Abscess Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Abscess Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Abscess Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Abscess Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Abscess Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Abscess Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Abscess Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Abscess Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 33
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2015* 35
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Durata Therapeutics, Inc., 2015* 36
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 37
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 38
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 39
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthem, Inc., 2015* 40
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Affinium Pharmaceuticals, Ltd., 2015* 41
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 42
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 43
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2015* 44
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2015* 45
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Wilford Hall Medical Center, 2015* 46
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 47
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 48
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Ann & Robert H. Lurie Children’s Hospital of Chicago, 2015* 49
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 50
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 51
Abscess Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2015* 52

List of Figures
Abscess Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Abscess Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Abscess Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Abscess Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Abscess Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Abscess Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Abscess Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Abscess Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Abscess to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Abscess Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Abscess Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Abscess to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Abscess Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Abscess Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Abscess Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Abscess Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Abscess Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Abscess Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Abscess Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Abscess Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Abscess Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Abscess Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Abscess Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 148

【掲載企業】

Bayer AG
Pfizer Inc.
The Medicines Company
Durata Therapeutics, Inc.
Johnson & Johnson
C. H. Boehringer Sohn AG & Co. KG
AstraZeneca PLC
Anthem, Inc.
Affinium Pharmaceuticals, Ltd.
Actavis plc

【レポートのキーワード】

膿瘍(Abscess)、治験、臨床試験、治験、治療薬

★調査レポート[膿瘍(Abscess):世界の治験レビュー(2015年上半期版)] (コード:GDHC2692CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[膿瘍(Abscess):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆